Clinical Updates
Drug approvals, guideline changes, and treatment advances
Biotech M&A Accelerates: AbbVie’s Apogee Deal Signals Return of Major Acquisitions
AbbVie's acquisition of Apogee Therapeutics marks a significant return to biotech M&A activity after an extended sector slowdown. Recent positive…
Editor's Top Picks
Candida auris endocarditis emerges as life-threatening infection in hospitalised patients
A rare but serious heart infection caused by the multidrug-resistant fungus Candida auris is emerging in hospitalised patients, presenting major…
Submit Your Paper →
More form Clinical Updates
Only Half of Eligible Adults Complete Bowel Cancer Screening in England
Health officials in England report that fewer than half of eligible 54-year-olds have completed free…
NHS to roll out two rapid diagnostic tests for endometriosis, potentially cutting years from diagnosis
The NHS will introduce two rapid diagnostic tests for endometriosis, aiming to cut the current…
Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures
Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The…
World-First Prenatal Surgery Saves Identical Twins from Life-Threatening Pregnancy Condition
Identical twins Nancy and Margo have become the first patients to survive in-utero surgery for…
ARPA-H funds $160 million gene-editing push for rare diseases after administrative delays
The U.S. Advanced Research Projects Agency for Health (ARPA-H) is awarding $160 million to seven…